Designing MedTech From the Market Backwards - Life Sciences Today Podcast Episode 64

Why It Matters

Applying a market‑first design cuts costly redesigns and accelerates patient access, giving medtech startups a competitive edge in a tightly regulated, reimbursement‑driven industry.

Key Takeaways

• Design medtech products by market needs, not just technology.
• Early stakeholder mapping prevents reimbursement and adoption hurdles.
• Pleoflow targets early cardiogenic shock with low‑profile device.
• Reverse‑engineered balloon pump adds valve for directional flow.
• Commercial‑first hiring accelerates product‑market fit in regulated space.

Summary

The Life Sciences Today podcast hosts Danny Lieberman and Teio Mastro Costopoulos discuss a market‑first approach to medical‑device development. Costopoulos, who sold his previous venture Limflow to Striker, now leads Pleoflow, a Greek‑based startup targeting early cardiogenic shock with a novel circulatory‑support device.

Costopoulos argues that product design must start with the label—who will buy, pay, and use the device—rather than waiting for clinical data. He stresses mapping physicians, hospitals, payers and patients from day one to avoid the “death valley” of reimbursement and coding delays that trap many regulated products.

He cites Limflow’s success, where a commercially‑savvy CEO shaped a limb‑ischemia therapy that secured reimbursement quickly. At Pleoflow, the team re‑engineered the decades‑old intra‑aortic balloon pump, adding a directional valve to create a low‑profile, low‑risk flow device that can stabilize patients before they deteriorate.

For medtech founders and investors, this market‑backward methodology reduces development risk, shortens time‑to‑reimbursement, and aligns product performance with real‑world clinical pathways—critical advantages in a sector where iteration cycles are long and regulatory stakes high.

Original Description

We're excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Theo Mastrokostopoulos, Co-Founder and CEO at Pleo Flow. This episode explores one of the biggest anti-patterns in medtech: building a technology first and only later trying to figure out who buys it, how it gets reimbursed, and whether the economics work. Mastrokostopoulos argues that successful medtech companies must design from commercialization backwards — starting with what you sell, how you price it, who buys it, and how those answers should shape product design from day one. The conversation uses Mastrokostopoulos’s current company, Pleo Flow, as a live example of how to align patient safety, physician usability, reimbursement, and hospital economics early.

For more great episodes of our Life Sciences Today Podcast, check out: https://www.healthcareittoday.com/category/life-sciences-today-podcasts/